Simone M. Goldinger - Researcher Profile

Publications

3 shown

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Antoni Ribas , Igor Puzanov , Reinhard Dummer +33 more

2015 The Lancet Oncology 1528 citations

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Eliezer M. Van Allen , Diana Miao , Bastian Schilling +19 more

Is cancer immunotherapy a private affair? Immune checkpoint blockade, a relatively new cancer treatment, substantially extends the survival of a subset of patients. Previous wor...

2015 Science 2876 citations

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

David Liu , Bastian Schilling , Derek Liu +33 more

2019 Nature Medicine 1011 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 5,415
Institution: University of Zurich

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-7995-7301

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.